In vitro functional analysis of human cytochrome P450 2A13 genetic variants: P450 2A13*2, *3, *4, and *10

References

• Ciliao, H. L., R. B. O. Camargo-Godoy, M. F. De Souza, M. B. Dos Reis, L. Iastrenski, V. D. Alvares Delfino, S. R. Rogatto, and I. M. De Syllos Colus. 2017. Association of UGT2B7, UGT1A9, ABCG2, and IL23R polymorphisms with rejection risk in kidney transplant patients. Journal Toxicogical Environment Health A 80:661–71. doi:10.1080/15287394.2017.1286922.
   PubMed Web of Science ®Google Scholar
• Desaulniers, D., C. Cummings-Lorbetskie, N. Li, G. H. Xiao, L. Marro, N. Khan, and K. Leingartner. 2017. Sodium bisulfite pyrosequencing revealed that developmental exposure to environmental contaminant mixtures does not affect DNA methylation of DNA repeats in Sprague-Dawley rats. Journal Toxicogical Environment Health A 80:32–52. doi:10.1080/15287394.2016.1231644.
   PubMed Web of Science ®Google Scholar
• DeVore, N. M., and E. E. Scott. 2012. Nicotine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone binding and access channel in human cytochrome P450 2A6 and 2A13 enzymes. The Journal of Biological Chemistry 287:26576–85. doi:10.1074/jbc.M112.372813.
   PubMed Web of Science ®Google Scholar
• Fujieda, M., H. Yamazaki, K. Kiyotani, A. Muroi, H. Kunitoh, H. Dosaka-Akita, Y. Sawamura, and T. Kamataki. 2003. Eighteen novel polymorphisms of the CYP2A13 gene in Japanese. Drug Metabolism and Pharmacokinetics 18:86–90. doi:10.2133/dmpk.18.86.
   PubMedGoogle Scholar
• Ginsberg, G., S. V. Vulimiri, Y. S. Lin, J. Kancherla, B. Foos, and B. Sonawane. 2017. A framework and case studies for evaluation of enzyme ontogeny in children’s health risk evaluation. Journal Toxicogical Environment Health A 80:569–93. doi:10.1080/15287394.2017.1369915.
   PubMed Web of Science ®Google Scholar
• Guengerich, F. P. 2008. Cytochrome P450 and chemical toxicology. Chemical Research in Toxicology 21:70–83. doi:10.1021/tx700079z.
   PubMed Web of Science ®Google Scholar
• Guengerich, F. P. 2015. Human cytochrome P450 enzymes. In Cytochrome P450: Structure, mechanism, and biochemistry, edited by P. R. Ortiz De Montellano, 253–912. 4th ed. London: Springer.
   Google Scholar
• Han, S., S. Choi, Y. J. Chun, C. H. Yun, C. H. Lee, H. J. Shin, H. S. Na, M. W. Chung, and D. Kim. 2012. Functional characterization of allelic variants of polymorphic human cytochrome P450 2A6 (CYP2A6*5, *7, *8, *18, *19, and *35). Biological & Pharmaceutical Bulletin 35:394–99. doi:10.1248/bpb.35.394.
   PubMed Web of Science ®Google Scholar
• Huang, H., Y. Ji, J. Zhang, Z. Su, M. Liu, J. Tong, C. Ge, T. Chen, and J. Li. 2017. Aberrant DNA methylation in radon and/or cigarette smoke-induced malignant transformation in BEAS-2B human lung cell line. Journal Toxicogical Environment Health A 80:1321–30. doi:10.1080/15287394.2017.1384156.
   PubMed Web of Science ®Google Scholar
• Jeong, D., H. G. Park, Y. R. Lim, Y. Lee, V. Kim, M. A. Cho, and D. Kim. 2018. Terfenadine metabolism of human cytochrome P450 2J2 containing genetic variations (G312R, P351L and P115L). Drug Metabolism and Pharmacokinetics 33:61–66. doi:10.1016/j.dmpk.2017.10.004.
   PubMed Web of Science ®Google Scholar
• Kumondai, M., H. Hosono, M. Maekawa, H. Yamaguchi, N. Mano, A. Oda, N. Hirasawa, and M. Hiratsuka. 2018. Functional characterization of 9 CYP2A13 allelic variants by assessment of nicotine C-oxidation and coumarin 7-hydroxylation. Drug Metabolism and Pharmacokinetics 33:82–89. doi:10.1016/j.dmpk.2017.11.004.
   PubMed Web of Science ®Google Scholar
• Lee, I. S., and D. Kim. 2011. Polymorphic metabolism by functional alterations of human cytochrome P450 enzymes. Archives of Pharmacal Research 34:1799–816. doi:10.1007/s12272-011-1103-2.
   PubMed Web of Science ®Google Scholar
• Lim, Y. R., S. Han, J. H. Kim, H. G. Park, G. Y. Lee, T. K. Le, C. H. Yun, and D. Kim. 2017. Characterization of a biflaviolin synthase CYP158A3 from Streptomyces avermitilis and its role in the biosynthesis of secondary metabolites. Biomolecular Therapeutics (Seoul) 25:171–76. doi:10.4062/biomolther.2016.182.
   PubMed Web of Science ®Google Scholar
• Lukas, C., S. Selinski, H. M. Prager, M. Blaszkewicz, J. G. Hengstler, and K. Golka. 2017. Occupational bladder cancer: Polymorphisms of xenobiotic metabolizing enzymes, exposures, and prognosis. Journal Toxicogical Environment Health A 80:439–52. doi:10.1080/10937404.2017.1304731.
   PubMed Web of Science ®Google Scholar
• Nunes, K. Z., M. Fioresi, V. B. Marques, and D. V. Vassallo. 2018. Acute copper overload induces vascular dysfunction in aortic rings due to endothelial oxidative stress and increased nitric oxide production. Journal Toxicogical Environment Health. doi:10.1080/15287394.2018.1437490.
   PubMed Web of Science ®Google Scholar
• Park, H. G., I. S. Lee, Y. J. Chun, C. H. Yun, J. B. Johnston, P. R. Montellano, and D. Kim. 2011. Heterologous expression and characterization of the sterol 14alpha-demethylase CYP51F1 from. Candida Albicans Archives Biochemical Biophysics 509:9–15. doi:10.1016/j.abb.2011.02.002.
   PubMed Web of Science ®Google Scholar
• Park, H. G., Y. R. Lim, C. Y. Eun, S. Han, J. S. Han, K. S. Cho, Y. J. Chun, and D. Kim. 2010. Candida albicans NADPH-P450 reductase: Expression, purification, and characterization of recombinant protein. Biochemical and Biophysical Research Communications 396:534–38. doi:10.1016/j.bbrc.2010.04.138.
   PubMed Web of Science ®Google Scholar
• Park, H. G., Y. R. Lim, S. Han, D. Jeong, and D. Kim. 2017. Enhanced purification of recombinant rat NADPH-P450 reductase by using a hexahistidine-tag. Journal of Microbiology and Biotechnology 27:983–89. doi:10.4014/jmb.1701.01028.
   PubMed Web of Science ®Google Scholar
• Shimada, T. 2017. Inhibition of carcinogen-activating cytochrome P450 enzymes by xenobiotic chemicals in relation to antimutagenicity and anticarcinogenicity. Toxicogical Researcher 33:79–96. doi:10.5487/TR.2017.33.2.079.
   PubMed Web of Science ®Google Scholar
• Shimada, T., K. Kakimoto, S. Takenaka, N. Koga, S. Uehara, N. Murayama, H. Yamazaki, D. Kim, F. P. Guengerich, and M. Komori. 2016a. Roles of human CYP2A6 and monkey CYP2A24 and 2A26 cytochrome P450 enzymes in the oxidation of 2,5,2ʹ,5ʹ-tetrachlorobiphenyl. Drug Metabolism and Disposition: The Biological Fate of Chemicals 44:1899–909. doi:10.1124/dmd.116.072991.
   PubMed Web of Science ®Google Scholar
• Shimada, T., N. Murayama, K. Kakimoto, S. Takenaka, Y. R. Lim, S. Yeom, D. Kim, H. Yamazaki, F. P. Guengerich, and M. Komori. 2018. Oxidation of 1-chloropyrene by human CYP1 family and CYP2A subfamily cytochrome P450 enzymes: Catalytic roles of two CYP1B1 and five CYP2A13 allelic variants. Xenobiotica 48:565–75. doi:10.1080/00498254.2017.1347306.
   PubMed Web of Science ®Google Scholar
• Shimada, T., S. Takenaka, N. Murayama, V. M. Kramlinger, J. H. Kim, D. Kim, J. Liu, M. K. Foroozesh, H. Yamazaki, F. P. Guengerich, and M. Komori. 2016b. Oxidation of pyrene, 1-hydroxypyrene, 1-nitropyrene and 1-acetylpyrene by human cytochrome P450 2A13. Xenobiotica 46:211–24. doi:10.3109/00498254.2015.1069419.
   PubMed Web of Science ®Google Scholar
• Smith, B. D., J. L. Sanders, P. R. Porubsky, G. H. Lushington, C. D. Stout, and E. E. Scott. 2007. Structure of the human lung cytochrome P450 2A13. The Journal of Biological Chemistry 282:17306–13. doi:10.1074/jbc.M702361200.
   PubMed Web of Science ®Google Scholar
• Su, T., Z. Bao, Q. Y. Zhang, T. J. Smith, J. Y. Hong, and X. Ding. 2000. Human cytochrome P450 CYP2A13: Predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Research 60:5074–79.
   PubMed Web of Science ®Google Scholar
• Tamaki, Y., M. Honda, Y. Muroi, T. Arai, H. Sugimura, Y. Matsubara, S. Kanno, M. Ishikawa, N. Hirasawa, and M. Hiratsuka. 2011. Novel single nucleotide polymorphism of the CYP2A13 gene in Japanese individuals. Drug Metabolism and Pharmacokinetics 26:544–47. doi:10.2133/dmpk.DMPK-11-SC-033.
   PubMed Web of Science ®Google Scholar
• von Wachenfeldt, C., T. H. Richardson, J. Cosme, and E. F. Johnson. 1997. Microsomal P450 2C3 is expressed as a soluble dimer in Escherichia coli following modification of its N-terminus. Archives of Biochemistry and Biophysics 339:107–14. doi:10.1006/abbi.1996.9859.
   PubMed Web of Science ®Google Scholar
• von Weymarn, L. B., C. Retzlaff, and S. E. Murphy. 2012. CYP2A6- and CYP2A13-catalyzed metabolism of the nicotine Delta5ʹ(1ʹ)iminium ion. The Journal of Pharmacology and Experimental Therapeutics 343:307–15. doi:10.1124/jpet.112.195255.
   PubMed Web of Science ®Google Scholar
• Zhou, S. F., J. P. Liu, and B. Chowbay. 2009. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metabolism Reviews 41:89–295.
   PubMed Web of Science ®Google Scholar